Otonomy, Inc. financial data

Industry
Pharmaceutical Preparations
Location
4796 Executive Drive, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 10, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 417 % -52.6%
Debt-to-equity 101 % +75.8%
Return On Equity -138 % -90.4%
Return On Assets -68.5 % -49.1%
Operating Margin -146K % -575%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.2M shares +0.83%
Common Stock, Shares, Outstanding 57.1M shares +0.67%
Common Stock, Value, Issued 57K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 36.7M USD +17.1%
Costs and Expenses 50.9M USD +8.53%
Operating Income (Loss) -50.9M USD -8.95%
Net Income (Loss) Attributable to Parent -52.3M USD -8.31%
Earnings Per Share, Basic -0.18 USD/shares +5.26%
Earnings Per Share, Diluted -0.18 USD/shares +5.26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.1M USD -50.9%
Cash, Cash Equivalents, and Short-term Investments 40.1M USD -54%
Assets, Current 43.9M USD -50.8%
Property, Plant and Equipment, Net 1.43M USD -10.5%
Operating Lease, Right-of-Use Asset 11.5M USD -12.2%
Assets 57.5M USD -45.1%
Accounts Payable, Current 616K USD +31.9%
Employee-related Liabilities, Current 2.33M USD -20.7%
Accrued Liabilities, Current 2.64M USD -11.8%
Liabilities, Current 25.3M USD +159%
Operating Lease, Liability, Noncurrent 10.7M USD
Liabilities 36.1M USD -5.76%
Retained Earnings (Accumulated Deficit) -594M USD -9.64%
Stockholders' Equity Attributable to Parent 21.4M USD -67.8%
Liabilities and Equity 57.5M USD -45.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.3M USD -16%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -194K USD -101%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 57.1M shares +0.67%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.5M USD -172%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.8M USD -50.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 360K USD +6.51%
Operating Lease, Liability 14.2M USD
Depreciation 195K USD -11.8%
Payments to Acquire Property, Plant, and Equipment 194K USD +49.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.3M USD -8.32%
Lessee, Operating Lease, Liability, to be Paid 18.2M USD
Property, Plant and Equipment, Gross 8.36M USD +6.73%
Operating Lease, Liability, Current 3.44M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.55M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 3.46M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.64M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.75M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 6.91M USD -2.96%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%